Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4189441000168110 | Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4189451000168112 | Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Is a | leuprorelin acetate 22.5 mg modified release injection, chamber | true | Inferred relationship | Some | ||
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Is a | Lucrin Depot 3-Month | true | Inferred relationship | Some | ||
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | has unit of use | chamber | true | Inferred relationship | Some | 1782763133 | |
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | has Australian BoSS | leuprorelin acetate | true | Inferred relationship | Some | 1782763132 | |
| Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | has intended active ingredient | leuprorelin | true | Inferred relationship | Some | 1782763132 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lucrin Depot 3-Month (1 x 22.5 mg chamber, 1 x 1.5 mL inert diluent chamber), 1 dual chamber syringe | has TPUU | True | Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Inferred relationship | Some | 2 |
| Lucrin Depot 3-Month (1 x 22.5 mg chamber, 1 x 1.5 mL inert diluent chamber), 1 dual chamber syringe | has TPUU | True | Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber | Inferred relationship | Some | 2 |
Reference Sets
Description inactivation indicator reference set
REFERS TO concept association reference set
Trade product unit of use reference set
FHIR